Use of ACE-inhibitors in Serbia in 2009 and 2010

Comparative analysis of the use of fixed combinations of drugs acting on the renin-angiotensin system, in the Republic of Serbia and Nordic countries, in the period 2010-2015

“…Za razliku od Norveške, gde je upotreba lekova prvog izbora za lečenje hipertenzije bila ujednačena, u Srbiji je bila dominantna potrošnja ACE inhibitora. Razlike u strukturi korišćenih ACE inhibitora odnosile su se na korišćenje skupljih lekova u Srbiji nego u Norveškoj, kako monokomponentnih, tako i njihovih kombinacija sa diureticima [13]. Studija koja je analizirala prepisivanje antihipertenzivnih lekova u Novom Sadu, tokom šestomesečnog perioda, 2011. i 2012. godine, takođe je pokazala neujednačenu zastupljenost lekova prvog izbora, kao i razlike u odnosu na prakse koje postoje u nordijskim zemljama (Finska i Norveška) [14].…”

“…As opposed to Norway, where the application of drugs of first choice for hypertension treatment was balanced, in Serbia, the consumption of ACE inhibitors was dominant. The differences in the structure of applied ACE inhibitors related to the application of more expensive drugs in Serbia than in Norway, both monocomponent drugs, and their combinations with diuretics [13]. A study analyzing the prescribing of antihypertensive drugs in Novi Sad, during a six-month period in 2011 and 2012, also demonstrated an uneven proportion of drugs of first choice, as well as differences to the practices that are in place in Nordic countries (Finland and Norway) [14].…”